Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-Smad TGF-beta signals.

Aristidis Moustakas1, Carl-Henrik Heldin

  • 1Ludwig Institute for Cancer Research, Biomedical Center, Uppsala University, Box 595, SE 751 24 Uppsala, Sweden. aris.moustakas@licr.uu.se

Journal of Cell Science
|August 18, 2005
PubMed
Summary

Transforming growth factor beta (TGF-β) signals primarily use Smad pathways, but non-Smad pathways also play crucial roles. These alternative routes regulate Smad activity and integrate signals with other cellular pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SHP2 negatively regulates TGF-β signaling by destabilizing the TGF-β type I receptor.

Cell communication and signaling : CCS·2026
Same author

Targeting oncogenic TβRI signaling inhibits androgen-independent prostate cancer growth and metastasis.

Signal transduction and targeted therapy·2026
Same author

Recent advances in TGF-β signaling: insights into regulation, pathophysiological function, and clinical translation.

Cell regeneration (London, England)·2026
Same author

G3BP1 is a SWI/SNF-bound regulator of transcription that modulates activation of STATs.

Bioscience reports·2026
Same author

RAB4A acts as a negative feedback regulator of extracellular vesicle secretion during TGF-β signaling.

The FEBS journal·2026
Same author

Correction: LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiation.

Oncogenesis·2026

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Smad pathways are established mediators of transforming growth factor beta (TGF-β) superfamily signalling to the nucleus.
  • Emerging evidence indicates that non-Smad pathways are also integral to TGF-β signalling.
  • These pathways offer alternative mechanisms for cellular responses to TGF-β.

Purpose of the Study:

  • To elucidate the mechanisms and significance of non-Smad pathways in TGF-β signalling.
  • To understand how non-Smad pathways interact with and modulate Smad-mediated responses.
  • To explore the integration of TGF-β signalling with other major cellular pathways via non-Smad transducers.

Main Methods:

  • Biochemical assays to investigate protein-protein interactions and modifications.
  • Developmental biology studies to observe physiological responses.
  • Analysis of signal transduction pathways, including Smad and non-Smad components.

Main Results:

  • Non-Smad signalling proteins modulate Smad activity through phosphorylation and direct interaction.
  • Smads can interact with and modulate other signalling proteins, influencing parallel pathways.
  • TGF-β receptors directly interact with or phosphorylate non-Smad proteins, initiating parallel signalling cascades.
  • Non-Smad pathways provide quantitative regulation and crosstalk with tyrosine kinase, G-protein-coupled, and cytokine receptor pathways.

Conclusions:

  • Non-Smad pathways are essential components of TGF-β signalling, complementing the canonical Smad pathway.
  • These alternative pathways offer regulatory control and facilitate crosstalk with other signalling networks.
  • Understanding non-Smad pathways is critical for a comprehensive view of TGF-β's physiological roles.

Related Experiment Videos